PRVB - PRVB Stock Skyrockets As Investors Cheer Teplizumab's Positive Results
PRVB stock in on fire and skyrockets as much as 300% after Provention Bio Inc (NASDAQ:PRVB) announced positive outcomes from its trial of teplizumab, its lead candidate.
PRVB stock Jumps BigNew Jersey-based Provention Bio, which is engaged in intercepting and treating diseases related to immune diseases, saw its stock soar on Thursday as the company announced positive details from the trial of teplizumab, its lead candidate. The product in question had its Phase 3 trial and is meant for the prevention of Type 1 diabetes, and if the product actually heads into the market, then ...
Get early insight on hidden secret gems on MicroSmallCap. Follow Crypto, Mining, Cannabis and Energy stocks and get free research reports here.
All content provided by MicroSmallCap is subject to our Terms Of Use and Disclaimer.